| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACLARIS THERAPEUTICS INC COM | 4,191,397 | 107,342,000 | 33.45% | ||
| 2 | Ascendis Pharma | 1,766,832 | 35,513,000 | 11.07% | ||
| 3 | EIGER BIOPHARMACEUTICALS INC | 1,787,091 | 23,929,000 | 7.46% | ||
| 4 | CODEXIS INC | 5,294,825 | 23,509,000 | 7.33% | ||
| 5 | Nabriva Therapeutics AG | 3,151,700 | 22,219,000 | 6.92% | ||
| 6 | ADVANCED ACCELERATOR APPLIC | 455,798 | 17,357,000 | 5.41% | ||
| 7 | Agile Therapeutics, Inc. | 2,019,955 | 14,099,000 | 4.39% | ||
| 8 | REGENXBIO INC COM | 990,449 | 13,876,000 | 4.32% | ||
| 9 | TREVENA INC | 1,728,000 | 11,664,000 | 3.63% | ||
| 10 | AIMMUNE THERAPEUTICS INC COM | 763,009 | 11,445,000 | 3.57% | ||
| 11 | COLUCID PHARMACEUTICALS INC COM | 225,000 | 8,584,000 | 2.68% | ||
| 12 | Foamix Pharmaceuticals Ltd. | 855,000 | 7,917,000 | 2.47% | ||
| 13 | Capnia, Inc. | 7,456,984 | 6,711,000 | 2.09% | ||
| 14 | AKARI THERAPEUTICS PLC | 527,842 | 4,492,000 | 1.40% | ||
| 15 | ProNAi Therapeutics, Inc. | 2,438,270 | 4,438,000 | 1.38% | ||
| 16 | DYNAVAX TECHNOLOGIES CORP | 359,828 | 3,775,000 | 1.18% | ||
| 17 | Carbylan Therapeutics Inc. | 4,204,562 | 1,934,000 | 0.60% | ||
| 18 | REVANCE THERAPEUTICS INC COM | 77,373 | 1,254,000 | 0.39% | ||
| 19 | OCERA THERAPEUTICS INC | 153,331 | 405,000 | 0.13% | ||
| 20 | Capnia, Inc. | 943,858 | 198,000 | 0.06% | ||
| 21 | PALATIN TECHNOLOGIES INC COM | 234,909 | 148,000 | 0.05% | ||
| 22 | Zosano Pharma Corp | 98,515 | 78,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-16-014565, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
